Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipiutide Ophthalmic Solution for Dry Eye (Phase II, China)
CTR20232869Phase 2Completed
- Sponsor
- Yicheng Kangtai
- Start
- Sep 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ipiutide in dry eye syndrome (DED), sponsored by Yicheng Kangtai. Started Sep 2023; status: completed.
02
Drugs
ipiutide
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20232869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232869.